Literature DB >> 14066040

TOXOPLASMIC RETINOCHOROIDITIS: A DOUBLE BLIND THERAPEUTIC STUDY.

T E ACERS.   

Abstract

Keywords:  CHORIORETINITIS; PLACEBOS; PREDNISONE; PYRIMETHAMINE; STATISTICS; SULFONAMIDE MIXTURES; TOXICOLOGIC REPORT; TOXOPLASMOSIS, OCULAR

Mesh：

Substances：

Year:  1964        PMID： 14066040     DOI： 10.1001/archopht.1964.00970010074010

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  16 in total

1.  Reliability of expert interpretation of retinal photographs for the diagnosis of toxoplasma retinochoroiditis.

Authors:  M R Stanford; L Gras; A Wade; R E Gilbert
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

2.  Does atovaquone prolong the disease-free interval of toxoplasmic retinochoroiditis?

Authors:  Sibylle Winterhalter; Katja Severing; Johannes Stammen; Anna Karina Maier; Erhard Godehardt; Antonia Maria Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-02       Impact factor: 3.117

3.  Manifestations and management of ocular toxoplasmosis.

Authors:  G R O'Connor
Journal:  Bull N Y Acad Med       Date:  1974-02

Review 4.  Ocular involvement in toxoplasmosis.

Authors:  A Rothova
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

Review 5.  Corticosteroids as adjuvant therapy for ocular toxoplasmosis.

Authors:  Smitha Jasper; Satyanarayana S Vedula; Sheeja S John; Saban Horo; Yasir J Sepah; Quan Dong Nguyen
Journal:  Cochrane Database Syst Rev       Date:  2017-01-26

Review 6.  Uveitis. A review.

Authors:  C Y Lowder; D H Char
Journal:  West J Med       Date:  1984-03

Review 7.  Antibiotics for human toxoplasmosis: a systematic review of randomized trials.

Authors:  Senaka Rajapakse; Mitrakrishnan Chrishan Shivanthan; Nilakshi Samaranayake; Chaturaka Rodrigo; Sumadhya Deepika Fernando
Journal:  Pathog Glob Health       Date:  2013-06       Impact factor: 2.894

8.  Therapy of ocular toxoplasmosis.

Authors:  A Rothova; H J Buitenhuis; C Meenken; G S Baarsma; T N Boen-Tan; P T de Jong; C M Schweitzer; Z Timmerman; J de Vries; M J Zaal
Journal:  Int Ophthalmol       Date:  1989-12       Impact factor: 2.031

9.  Azithromycin for ocular toxoplasmosis.

Authors:  A Rothova; L E Bosch-Driessen; N H van Loon; W F Treffers
Journal:  Br J Ophthalmol       Date:  1998-11       Impact factor: 4.638

Review 10.  Corticosteroids as adjuvant therapy for ocular toxoplasmosis.

Authors:  Smitha Jasper; Satyanarayana S Vedula; Sheeja S John; Saban Horo; Yasir J Sepah; Quan Dong Nguyen
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.